✦ LIBER ✦

CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment

✍ Scribed by Ede Frecska; András Perényi; György Bagdy; Katalin Révai

Book ID: 119094687
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 435 KB
Volume: 16
Category: Article
ISSN: 0165-1781
DOI: 10.1016/0165-1781(85)90109-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decrease of CSF dopamine, its metabolite

Decrease of CSF dopamine, its metabolites, and noradrenalin after withdrawal of chronic neuroleptic treatment in schizophrenic patients

✍ György Bagdy; András Perényi; Mihály Arató; Ed Rotstein 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Long-term neuroleptic treatment of chron

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

✍ K. J. Zander; B. Fischer; R. Zimmer; M. Ackenheil 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 578 KB

In 17 chronic schizophrenic patients under chronic neuroleptic treatment for 13 years, a 30-day drug withdrawal resulted in early relapse of four patients, slight deterioration in five, and slight amelioration in eight patients. No incidence of neuroleptic symptoms such as tardive dyskinesia occurre

Neuroendocrine effects of clonidine in c

Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology

✍ F. Müller-Spahn; M. Ackenheil; M. Albus; C. Botschev; D. Naber; D. Welter 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 642 KB

Neuroendocrine effects of apomorphine in

Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: Relations to psychopathology and tardive dyskinesia

✍ F. Müller-Spahn; M. Ackenheil; M. Albus; G. May; D. Naber; D. Welter; K. Zander 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 588 KB